2023 Otto Schmitt Lecture (Kuntz) | Institute for Engineering in Medicine Archives

"A MedTech Leader's Perspective on the Digital Health Revolution"

11:00 AM -1:00 PM
Tuesday, February 28th, 2023
Mississippi Room, Coffman Memorial Union

BIO

Richard (Rick) Kuntz recently retired from Medtronic as the company’s Chief Medical and Scientific Officer, where he served as a member on the Company’s Executive Committee. In this role, Kuntz oversaw the company’s medical affairs, health policy and reimbursement, clinical research activities, and corporate technology.

Far from actually “retired,” Dr. Kuntz serves on the boards of Rockley Photonics, ZimVie, and Identiv and has several active research collaborations with medical device and digital health experts at Medtronic, the University of Minnesota, Cleveland Clinic, and other institutions around the country. He is also a working group member of NIH’s Helping to End Addiction Long-term® program.

Prior to his seventeen years at Medtronic, Dr. Kuntz was the founder and chief scientific officer of the Harvard Clinical Research Institute in Boston, a university-based contract research organization that coordinated NIH and industry clinical trials with the U.S. Food and Drug Administration. He directed numerous multicenter clinical trials and authored more than 250 original peer-reviewed publications. Dr. Kuntz served as an associate professor of medicine at Harvard Medical School, chief of the division of clinical biometrics, and as an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women’s Hospital in Boston. In addition, he served as a founding Governor of the Patient Centered Outcomes Research Institute, part of the U.S. Affordable Care Act, from 2010-2018.

Dr. Kuntz also served as an advisor to multiple national and regional committees, in the National Academy of Medicine and NIH.

Dr. Kuntz graduated from Miami University and received his medical degree from Case Western Reserve University School of Medicine. He completed his residency and chief residency in internal medicine at the University of Texas Southwestern Medical School, Parkland Hospital and then completed fellowships in cardiovascular diseases and interventional cardiology at Harvard Medical School and the Beth Israel Hospital in Boston. Dr. Kuntz received his Master’s of Science in Biostatistics from the Harvard T.H. Chan School of Public Health.